FDA Approved: FELBAMATE — Original Application (Taro Pharmaceuticals U.S.A., inc.)

View source ↗

Summary

FDA approves the original ANDA application for Felbamate from Taro Pharmaceuticals U.S.A., enabling a generic version of the antiepileptic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• FELBAMATE (felbamate)

Snippet

ORIG AP for FELBAMATE (FELBAMATE)